Literature DB >> 20452944

Mouse models of p53 functions.

Guillermina Lozano1.   

Abstract

Studies in mice have yielded invaluable insight into our understanding of the p53 pathway. Mouse models with activated p53, no p53, and mutant p53 have queried the role of p53 in development and tumorigenesis. In these models, p53 is activated and stabilized via redundant posttranslational modifications. On activation, p53 initiates two major responses: inhibition of proliferation (via cell-cycle arrest, quiescence, senescence, and differentiation) and induction of apoptosis. Importantly, these responses are cell-type and tumor-type-specific. The analysis of mutant p53 alleles has established a gain-of-function role for p53 mutants in metastasis. The development of additional models that can precisely time the oncogenic events in single cells will provide further insight into the evolution of tumors, the importance of the stroma, and the cooperating events that lead to disruption of the p53 pathway. Ultimately, these models should serve to study the effects of novel drugs on tumor response as well as normal homeostasis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20452944      PMCID: PMC2845198          DOI: 10.1101/cshperspect.a001115

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Biol        ISSN: 1943-0264            Impact factor:   10.005


  81 in total

1.  Ser18 and 23 phosphorylation is required for p53-dependent apoptosis and tumor suppression.

Authors:  Connie Chao; Deron Herr; Jerold Chun; Yang Xu
Journal:  EMBO J       Date:  2006-06-01       Impact factor: 11.598

2.  Mdm2, but not Mdm4, protects terminally differentiated smooth muscle cells from p53-mediated caspase-3-independent cell death.

Authors:  L S M Boesten; S M Zadelaar; S De Clercq; S Francoz; A van Nieuwkoop; E A L Biessen; F Hofmann; S Feil; R Feil; A G Jochemsen; C Zurcher; L M Havekes; B J M van Vlijmen; J-C Marine
Journal:  Cell Death Differ       Date:  2006-05-26       Impact factor: 15.828

Review 3.  Keeping p53 in check: essential and synergistic functions of Mdm2 and Mdm4.

Authors:  J-C Marine; S Francoz; M Maetens; G Wahl; F Toledo; G Lozano
Journal:  Cell Death Differ       Date:  2006-06       Impact factor: 15.828

4.  Synergistic roles of Mdm2 and Mdm4 for p53 inhibition in central nervous system development.

Authors:  Shunbin Xiong; Carolyn S Van Pelt; Ana C Elizondo-Fraire; Geng Liu; Guillermina Lozano
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-21       Impact factor: 11.205

5.  The pathological response to DNA damage does not contribute to p53-mediated tumour suppression.

Authors:  M A Christophorou; I Ringshausen; A J Finch; L Brown Swigart; G I Evan
Journal:  Nature       Date:  2006-09-06       Impact factor: 49.962

6.  Mdm2 is critically and continuously required to suppress lethal p53 activity in vivo.

Authors:  Ingo Ringshausen; Clodagh C O'Shea; Andrew J Finch; Lamorna Brown Swigart; Gerard I Evan
Journal:  Cancer Cell       Date:  2006-12       Impact factor: 31.743

Review 7.  Regulating the p53 pathway: in vitro hypotheses, in vivo veritas.

Authors:  Franck Toledo; Geoffrey M Wahl
Journal:  Nat Rev Cancer       Date:  2006-12       Impact factor: 60.716

8.  Mdm4 and Mdm2 cooperate to inhibit p53 activity in proliferating and quiescent cells in vivo.

Authors:  Sarah Francoz; Pascal Froment; Sven Bogaerts; Sarah De Clercq; Marion Maetens; Gilles Doumont; Eric Bellefroid; Jean-Christophe Marine
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-21       Impact factor: 11.205

9.  p53 functions as a negative regulator of osteoblastogenesis, osteoblast-dependent osteoclastogenesis, and bone remodeling.

Authors:  Xueying Wang; Hui-Yi Kua; Yuanyu Hu; Ke Guo; Qi Zeng; Qiang Wu; Huck-Hui Ng; Gerard Karsenty; Benoit de Crombrugghe; James Yeh; Baojie Li
Journal:  J Cell Biol       Date:  2005-12-27       Impact factor: 10.539

10.  Osteoblast differentiation and skeletal development are regulated by Mdm2-p53 signaling.

Authors:  Christopher J Lengner; Heather A Steinman; James Gagnon; Thomas W Smith; Janet E Henderson; Barbara E Kream; Gary S Stein; Jane B Lian; Stephen N Jones
Journal:  J Cell Biol       Date:  2006-03-13       Impact factor: 10.539

View more
  50 in total

1.  p53-Dependent induction of PVT1 and miR-1204.

Authors:  Anthony M Barsotti; Rachel Beckerman; Oleg Laptenko; Konrad Huppi; Natasha J Caplen; Carol Prives
Journal:  J Biol Chem       Date:  2011-11-22       Impact factor: 5.157

Review 2.  Apoptosis and aging: increased resistance to apoptosis enhances the aging process.

Authors:  Antero Salminen; Johanna Ojala; Kai Kaarniranta
Journal:  Cell Mol Life Sci       Date:  2010-11-30       Impact factor: 9.261

Review 3.  p53 and regulation of bioactive sphingolipids.

Authors:  Linda A Heffernan-Stroud; Lina M Obeid
Journal:  Adv Enzyme Regul       Date:  2010-10-28

4.  CP-31398 prevents the growth of p53-mutated colorectal cancer cells in vitro and in vivo.

Authors:  Xingxing He; Xinjuan Kong; Junwei Yan; Jingjun Yan; Yunan Zhang; Qian Wu; Ying Chang; Haitao Shang; Qian Dou; Yuhu Song; Fang Liu
Journal:  Tumour Biol       Date:  2015-02-08

5.  Increase developmental plasticity of human keratinocytes with gene suppression.

Authors:  Shengwen Calvin Li; Yangsun Jin; William G Loudon; Yahui Song; Zhiwei Ma; Leslie P Weiner; Jiang F Zhong
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-18       Impact factor: 11.205

6.  It Takes 15 to Tango: Making Sense of the Many Ubiquitin Ligases of p53.

Authors:  Ian M Love; Steven R Grossman
Journal:  Genes Cancer       Date:  2012-03

7.  p53 and miR-34a Feedback Promotes Lung Epithelial Injury and Pulmonary Fibrosis.

Authors:  Shwetha K Shetty; Nivedita Tiwari; Amarnath S Marudamuthu; Bijesh Puthusseri; Yashodhar P Bhandary; Jian Fu; Jeffrey Levin; Steven Idell; Sreerama Shetty
Journal:  Am J Pathol       Date:  2017-03-06       Impact factor: 4.307

8.  Tumor suppression in the absence of p53-mediated cell-cycle arrest, apoptosis, and senescence.

Authors:  Tongyuan Li; Ning Kon; Le Jiang; Minjia Tan; Thomas Ludwig; Yingming Zhao; Richard Baer; Wei Gu
Journal:  Cell       Date:  2012-06-08       Impact factor: 41.582

9.  Using Mouse Models to Explore MDM-p53 Signaling in Development, Cell Growth, and Tumorigenesis.

Authors:  Hugh S Gannon; Stephen N Jones
Journal:  Genes Cancer       Date:  2012-03

10.  Mutant p53 prolongs NF-κB activation and promotes chronic inflammation and inflammation-associated colorectal cancer.

Authors:  Tomer Cooks; Ioannis S Pateras; Ohad Tarcic; Hilla Solomon; Aaron J Schetter; Sylvia Wilder; Guillermina Lozano; Eli Pikarsky; Tim Forshew; Nitzan Rosenfeld; Nitzan Rozenfeld; Noam Harpaz; Steven Itzkowitz; Curtis C Harris; Varda Rotter; Vassilis G Gorgoulis; Moshe Oren
Journal:  Cancer Cell       Date:  2013-05-13       Impact factor: 31.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.